Physician profile
Philip K Robb
NPI 1356390876
$1,838.36
in general payments reported to CMS, 2019-2025
12 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $44.01 · 2021: $152 · 2022: $624 · 2023: $241 · 2024: $129 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $569.05 | 2019-2023 | Xeomin |
| Intersect Ent, INC. | $220.20 | 2019 | |
| Acteon INC | $175.00 | 2022 | |
| Medtronic, INC. | $170.95 | 2022-2025 | Stealthstation S8 Platform, Propel |
| Aerin Medical INC. | $155.56 | 2023 | |
| Genzyme Corporation | $139.55 | 2024-2025 | |
| Galderma Laboratories, L.P. | $138.45 | 2024-2025 | Dysport |
| Medical Device Business Services, INC. | $88.58 | 2022 | |
| Allergan, INC. | $74.19 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $47.90 | 2021 | |
| Olympus America INC. | $43.65 | 2019-2024 | Olympus |
| Acclarent, INC | $15.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Robb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.